Role of mast cell-derived exosomes in exacerbating neuronal injury of experimental cerebral malaria
- PMID: 40598575
- PMCID: PMC12220399
- DOI: 10.1186/s13071-025-06863-3
Role of mast cell-derived exosomes in exacerbating neuronal injury of experimental cerebral malaria
Abstract
Background: Cerebral malaria (CM), a fatal neurological complication of Plasmodium falciparum infection, is partially driven by neuronal injury. Emerging evidence highlights exosomes as vital mediators of mast cell-neuron interactions in neurological disease progression. While mast cells and their exosomes were previously shown to exacerbate experimental cerebral malaria (ECM) severity, the specific role of mast cell-derived exosomes in CM-associated neuronal injury remains unclear.
Methods: Exosomes were isolated from resting and lipopolysaccharide (LPS)-activated P815 mast cells (denoted as RE and AE, respectively) and characterized. These exosomes were administered to ECM mice and Plasmodium berghei ANKA (PbA)-infected red blood cell (iRBC)-stimulated neuronal HT-22 cells to investigate their functional impact and mechanisms.
Results: Both RE and AE exhibited spherical morphology (20-100 nm diameter) and expressed exosomal markers (CD9, CD63, and CD81). Compared to infected controls, RE and AE treatments significantly reduced survival time, increased ECM incidence, and exacerbated brain pathology, blood-brain barrier disruption, neuronal injury, and apoptosis. Furthermore, RE and AE administration elevated messenger RNA (mRNA) levels of pro-inflammatory cytokines (interleukin [IL]-6, tumor necrosis factor alpha [TNF-α], and IL-1β) and increased numbers of neurons expressing endoplasmic reticulum (ER) stress markers (GRP78, CHOP, p-IRE1, XBP-1). Notably, AE treatment induced higher morbidity/mortality rates, more severe neuronal injury, and greater ER stress marker expression than RE. In vitro, RE-treated iRBC-stimulated neuronal HT-22 cells showed higher GRP78, CHOP, and XBP-1 mRNA levels than AE-treated cells. MicroRNA (miRNA) sequencing revealed three downregulated miRNAs (miR-330-3p, miR-185-5p, and miR-379-5p) and six upregulated miRNAs (miR-155-5p, miR-423-3p, miR-187-3p, miR-29c-3p, miR-188-5p, miR-192-5p) in AE versus RE, all previously implicated in targeting GRP78, CHOP, or XBP-1.
Conclusions: Mast cell-derived exosomes, particularly those from activated cells (AE), exacerbated ECM neuronal injury through partial activation of ER stress pathways.
Keywords: Cerebral malaria; Endoplasmic reticulum stress; Exosomes; Mast cells; Neuron.
© 2025. The Author(s).
Conflict of interest statement
Declarations. Ethics approval and consent to participate: All animal procedures were reviewed and approved by the Animal Ethics Committee of Guangdong Pharmaceutical University (No. gdpulac2023001). Consent for publication: Not applicable. Competing interests: The authors declare no competing interests.
Figures













Similar articles
-
Malaria-derived exosomes exacerbate liver injury during blood stage of Plasmodium berghei infection.Acta Trop. 2023 Mar;239:106815. doi: 10.1016/j.actatropica.2023.106815. Epub 2023 Jan 3. Acta Trop. 2023. PMID: 36608749
-
Mast cells-derived exosomes worsen the development of experimental cerebral malaria.Acta Trop. 2021 Dec;224:106145. doi: 10.1016/j.actatropica.2021.106145. Epub 2021 Sep 22. Acta Trop. 2021. PMID: 34562426
-
IFNγ-inducible Gbp4 and Irgb6 contribute to experimental cerebral malaria pathology in the olfactory bulb.mBio. 2025 Aug 13;16(8):e0124925. doi: 10.1128/mbio.01249-25. Epub 2025 Jul 3. mBio. 2025. PMID: 40607809 Free PMC article.
-
MicroRNAs in oral fluids (saliva and gingival crevicular fluid) as biomarkers in orthodontics: systematic review and integrated bioinformatic analysis.Prog Orthod. 2021 Oct 11;22(1):31. doi: 10.1186/s40510-021-00377-1. Prog Orthod. 2021. PMID: 34632546 Free PMC article.
-
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.Cochrane Database Syst Rev. 2021 Apr 19;4(4):CD011535. doi: 10.1002/14651858.CD011535.pub4. Cochrane Database Syst Rev. 2021. Update in: Cochrane Database Syst Rev. 2022 May 23;5:CD011535. doi: 10.1002/14651858.CD011535.pub5. PMID: 33871055 Free PMC article. Updated.
References
-
- WHO. World malaria report 2023. Geneva: World Health Organization; 2023.
-
- Hadjilaou A, Brandi J, Riehn M, Friese MA, Jacobs T. Pathogenetic mechanisms and treatment targets in cerebral malaria. Nat Rev Neurol. 2023;19:688–709. - PubMed
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous